Qkine, a Cambridge, UK-based manufacturer of animal-free, bioactive, and innovative proteins and growth factors for life science applications, raised £4M in funding.
The round was led by Parkwalk Advisors Ltd and Downing Ventures.
The company intends to use the funds to enable substantial scaling of manufacturing, R&D and commercial functions and to expand into additional global markets.
Led by Dr Catherine Elton, CEO, Qkine combines proprietary protein production process development with protein engineering techniques to develop purity products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine, and cellular agriculture sectors.
Qkine is an ISO 9001:2015 certified company with an established global distribution network.
FinSMEs
15/12/2022